A meta-analysis linking PCSK9 LOF variants and diabetes risk demonstrated the correlation between decreased LDL-C and increased risk of diabetes, with an odds ratio of 1.19 (95% confidence interval 1.02–1.38) for each 1 mmol/L decrease in LDL-C (Lotta et al., 2016). Here, PCSK9 is linked to diabetes mellitus.